| Authors: |
Kotch C; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Perreault S; Division of Child Neurology, Department of Neurosciences, Université de Montréal, Montréal, QC, H3T 1J4, Canada., Power P; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia., Adams DJ; Wellcome Trust Sanger Institute, Cambridge, UK., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Avery RA; Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Cambridge, Massachusetts, USA., Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., de Blank P; Department of Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Entz-Werle N; Pediatric Oncology Department, University Hospitals of Strasbourg, 67098, Strasbourg, France, EN-HOPE SMART4CBT Research Center, PEDIACRIEX, Lille, Nancy, Strasbourg, University Hospitals of Strasbourg, France., Fangusaro J; Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA; Aflac Cancer Center, Atlanta, Georgia, USA., Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital; Pediatric Neuro-Oncology, Precision Cancer Medicine, South Australia Health and Medical Research Institute; South Australia Immunogenomics Cancer Institute, Adelaide University, Adelaide, South Australia, Australia., Hawkins C; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Research Institute, Toronto, Ontario, Canada., Jacques TS, Jones DT; German Cancer Research Center (DKFZ), Hopp Children's Cancer Center Heidelberg (KiTZ) and Division of Pediatric Glioma Research (B360), Heidelberg, Germany., Kann BH; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Kranendonk ME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Levine A; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Research Institute, Toronto, Ontario, Canada., Ligon KL; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Martinez-Barbera JP; Developmental Biology and Cancer, UCL GOS Institute of Child Health, London, UK., Meijer L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Milde T; German Cancer Research Center (DKFZ), Hopp Children's Cancer Center Heidelberg (KiTZ) and Division of Pediatric Glioma Research (B360), Heidelberg, Germany.; University Hospital Jena, Department of Pediatrics and Adolescent Medicine, Friedrich Schiller University Jena, Jena, Germany and Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany., Mueller S; Department of Neurology and Pediatrics, University of California San Francisco, San Francisco, California, USA., Mulcahy Levy JM; Morgan Adams Foundation Brain Tumor Research Program, Department of Pediatrics, Children's Hospital Colorado, and University of Colorado School of Medicine, Aurora, Colorado, USA., Nakano Y; Department of Histopathology, Great Ormond Street Hospital for Children, UCL GOS Institute of Child Health, London, UK., Packer RJ; Brain Tumor Institute and Gilbert Family Neurofibromatosis Institute, Children's National Hospital, Washington, District of Columbia, USA.; Division of Oncology, Children's National Hospital, Washington, District of Columbia, USA., Pfister S; German Cancer Research Center (DKFZ), Hopp Children's Cancer Center Heidelberg (KiTZ) and Division of Pediatric Glioma Research (B360), Heidelberg, Germany., Raabe E; Division of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Robison NJ; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA., Tabori U; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Research Institute, Toronto, Ontario, Canada., Yeo KK; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Vinitsky A; St Jude Children's Research Hospital, Memphis, Tennessee, 38103, USA., Zhu Y; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Fisher MJ; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Hargrave D; University College London Great Ormond Street Institute of Child Health, London, UK., Kilburn LB; Division of Oncology, Children's National Hospital, Washington, District of Columbia, USA. |
